魚躍醫療(002223.SZ):重慶螞蟻消費金融正式成立
格隆匯6月7日丨魚躍醫療(002223.SZ)公佈,此前公吿披露,公司於2020年8月21日召開第四屆董事會第二十六次臨時會議,審議通過了《關於參與投資設立消費金融公司》的議案,同意公司與螞蟻科技集團股份有限公司(“螞蟻集團”)、南洋商業銀行有限公司、國泰世華銀行(中國)有限公司、寧德時代新能源科技股份有限公司、北京千方科技股份有限公司、中國華融資產管理股份有限公司共同出資設立重慶螞蟻消費金融有限公司。
2020年9月17日,公司收到螞蟻集團轉交的《中國銀保監會關於籌建重慶螞蟻消費金融有限公司的批覆》(銀保監復﹝2020﹞602號),同意螞蟻集團在重慶市籌建重慶螞蟻消費金融有限公司。
2021年6月4日,重慶螞蟻消費金融有限公司已按照相關法律法規的要求,在重慶市南岸區市場監督管理局註冊登記並取得營業執照,重慶螞蟻消費金融有限公司正式成立,其註冊資本人民幣80億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.